Innovative Proteomics RayBiotech specializes in advanced proteomic discovery tools, including high-density antibody arrays and ELISA technologies, which positions it as a key vendor for pharmaceutical and research institutions seeking cutting-edge biomarker detection solutions.

Global Research Reach With customers in 85 countries and a broad product portfolio, RayBiotech offers extensive market opportunities to expand its international sales channels, especially in emerging markets investing heavily in biotech research.

Strategic Partnerships Recent collaborations with Venebio Group and NFL Alumni demonstrate RayBiotech’s ability to partner on drug development and health testing initiatives, opening doors for sales of diagnostic kits, research reagents, and development services.

Financial Stability Generating revenue between 25 million and 50 million dollars with grant support from the Israel-U.S. Binational Foundation provides a solid financial foundation to fund new product development and market expansion efforts.

Tech-Driven Approach RayBiotech’s use of modern technology stack including cloud services and web analytics indicates a focus on operational efficiency and customer engagement, creating opportunities for targeted sales strategies and digital marketing partnerships.